Breathe Easy

Breathe Easy Therapeutics is focused on developing innovative therapeutic devices and formulations specifically for cystic fibrosis (CF). The company aims to enhance the treatment options available to clinicians and patients managing this life-threatening genetic condition. Its devices are designed to liquefy and reduce the viscosity of the thick mucus that obstructs airflow in the lungs and hinders enzyme distribution in the digestive system. By improving these aspects of treatment, Breathe Easy Therapeutics seeks to provide better outcomes for those affected by cystic fibrosis.